Jean-Charles SORIA

Jean-harles Soria: is Amgen’s senior vice president of Oncology within Global Development. Soria joins Amgen from Institut Gustave Roussy, where he was appointed director general by France’s minister of health and solidarity.

Soria is a medical oncologist and professor of medicine at Paris-Saclay University. He holds a doctorate in molecular biology.

He completed his training during a two-year appointment at the MD Anderson Cancer Center in Houston, Texas, U.S., where he was an associate professor from 2013 to 2017. He also served at the director of the Gustave Roussy SIRIC Socrate (Integrated Cancer Research Site) from 2012 to 2017.

From 2017 to 2019 he held the role of senior vice president, Research and Development in Oncology, with AstraZeneca in Gaithersburg, Maryland, U.S., where he led research teams responsible for strategy and for development of new agents in immuno-oncology, cell therapy and conjugated antibodies. Additionally, he has authored or co-authored more than 670 articles in leading international journals and has appeared on lists of the most influential research scientists in the world.

PEGASCY governance

Founders

Jean-harles Soria: is Amgen’s senior vice president of Oncology within Global Development. Soria joins Amgen from Institut Gustave Roussy

Jean-Charles

SORIA

Jean-Pierre Armand MD, MSc, is certified in Medical Oncology (University of Toulouse III and Paris XI). He was recently General Director of the Institut Claudius Regaud in Toulouse.

Jean-Pierre

ARMAND

Fabrice André: Director of Research at Gustave Roussy since February 2020, Prof. Fabrice André coordinates the Institute's medical-scientific research programs, in conjunction with the Medical Director.

Fabrice

ANDRÉ

Aurelie Marabelle: MD, PhD, is a Senior Medical Oncologist in the Drug Development Department (DITEP), a group leader in Prof Laurence Zitvogel’s lab (INSERM U1015)

Aurélien

MARABELLE

Sébastien Bazin: After five years working in several financial positions in New York, San Francisco and London

Sébastien

BAZIN

Thierry Bruhat: he spent more than 20 years in supporting innovation projects and policies based on cooperation between companies, research

Thierry

BRUHAT

Board

Jean-Pierre Armand MD, MSc, is certified in Medical Oncology (University of Toulouse III and Paris XI). He was recently General Director of the Institut Claudius Regaud in Toulouse.